Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Testosteronsubstitutionsbehandling af hypogonadisme hos mænd med prostatacancer

Research output: Contribution to journalReviewResearchpeer-review

  1. Multidisciplinær håndtering af svær jernforgiftning som følge af suicidalforsøg

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oxygen under tryk som behandling

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparison between temporal and rectal temperature measurement

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Definition, pathology and pathogenesis of osteoarthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Definition, pathology and pathogenesis of osteoarthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Value of 68Ga-PSMA PET/CT Following Equivocal 18F-NaF PET/CT in Prostate Cancer Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Varicocele Testis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Review of injection techniques for spermatogonial stem cell transplantation

    Research output: Contribution to journalReviewResearchpeer-review

  5. Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Hypogonadism and prostate cancer (PCa) often coincide with increasing age. Recent reviews have found no evidence to suggest an increased risk of developing PCa with testosterone replacement therapy (TRT). The same lack of PCa risk is found in studies looking at men receiving TRT after radical prostatectomy for PCa. Reports on TRT in men on active surveillance are very few. In summary, current evidence does not support an association between TRT and an increased risk of PCa. Nevertheless, sufficiently powered trials with longer follow-up are warranted before making final conclusions.

Translated title of the contributionTestosterone replacement therapy for hypogonadism in men with prostate cancer
Original languageDanish
JournalUgeskrift for Laeger
Volume179
Issue number9
Pages (from-to)2
Number of pages6
ISSN0041-5782
Publication statusPublished - 27 Feb 2017

    Research areas

  • English Abstract, Journal Article

ID: 50099067